The makers of Plavix, a popular blood-thinning drug, are the target of multiple lawsuits by users and third-parties. The plaintiffs allege that the pharmaceutical company marketed the drug in disregard of its potential health risks. The plaintiffs state that the manufacturers “over-promoted” the drug and were twice ordered by the FDA to withdraw ads that made overly broad claims. Plavix was the second most widely prescribed drug in the world in 2005, with sales in the U.S. of about $5.9 billion.
For the full article.